Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(11 sites)
United States
Mayo Clinic Arizona, Phoenix, Arizona Mayo Clinic Florida, Jacksonville, Florida Dana Farber Cancer institution, Boston, Massachusetts Mayo Clinic Rochester, Rochester, Minnesota Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York, New York Icahn School of Medicine at Mount Sinai，The Tisch Cancer Institute, New York, New York China
Beijing Chaoyang Hospital Capital Medical University, Beijing, Beijing Municipality Sun Yat-sen University Cancer Center, Guangzhou, Guangdong Henan Cancer Hospital, Zhengzhou, Henan Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, Tianjin Municipality The First Affiliated Hospital Zhejiang University School of Medicine, Hanzhou, Zhejiang